Option GridTM decision aid:

Parkinson's disease: medication options

This process will guide you through the choices available to you.

Your responses will help us help others. In less than 10 minutes, you will be able to download your own personal summary to share as you wish. Your information will be safe, anonymous and will not be shared with anyone

Interactive Option GridTM decision aid:

Parkinson's disease: medication options

Your summary

Next >

Information about you

We use this information for research purposes only. Data about your individual identity is not collected.

Before we begin:

Do you already have a preferred option in mind?

Click the option you are currently leaning towards:
How strong is your current preference for this option?

Sure Survey

In this interactive tool, you will be comparing multiple options. You may already have a preferred option in mind. Before you start, please answer these questions:

Question: 1

Do you feel sure about the best choice for you?

Your answer:

check

Yes

check

No

Question: 2

Do you know the benefits and risks of each option?

Your answer:

check

Yes

check

No

Question: 3

Are you clear about which benefits and risks matter most to you?

Your answer:

check

Yes

check

No

Question: 4

Do you have enough support and advice to make a choice?

Your answer:

check

Yes

check

No

Self check

What do you already know?

Before you start the interactive journey, let's see what you already know about this topic. You will be able to redo the self-check at the end of the interactive journey to see if your score changes. You aren't being graded!

Question: 1

Levodopa and dopamine agonists (enhancers) work equally well at improving mobility.

Your answer:

check

True

check

False

This is an explanation

Question: 2

More people develop involuntary movements with levodopa compared with dopamine agonists (enhancers).

Your answer:

check

True

check

False

This is an explanation

Question: 3

Impulsive behaviors, such as overeating or gambling, may happen when taking either levodopa or dopamine agonists.

Your answer:

check

True

check

False

This is an explanation

Question: 4

You will probably take the same amount of levodopa for many years.

Your answer:

check

True

check

False

This is an explanation

Question: 5

Taking dopamine agonists means that you won’t have to take levodopa in the future.

Your answer:

check

True

check

False

This is an explanation

Frequently Asked Question #1:

What does this treatment involve?

What does this treatment involve?
How important is this question to you?

Not important at all

0 1 2 3 4 5

Extremely important

Frequently Asked Question #2:

Will this treatment help with my symptoms?

Will this treatment help with my symptoms?
How important is this question to you?

Not important at all

0 1 2 3 4 5

Extremely important

Frequently Asked Question #3:

What are the chances of developing involuntary movements?

51 out of every 100 people (51%) taking levodopa develop involuntary movements in the first 5 years.

This is because the effect of the medication ‘wears off’ over time.

Levodopa (L-DOPA)

check
Data viewer 51 in 100 (51%)

22 out of every 100 people (22%) taking dopamine agonists develop involuntary movements in the first five years.

This is because the effect of the medication ‘wears off’ over time.

Dopamine agonist (enhancer)

check
Data viewer 22 in 100 (22%)
What are the chances of developing involuntary movements?
How important is this question to you?

Not important at all

0 1 2 3 4 5

Extremely important

Frequently Asked Question #4:

What are the chances of developing impulsive behaviors, like overdoing gambling, eating, sex or shopping?

About 7 out of every 100 people (7%) taking levodopa develop impulsive behaviors.


Impulsive behaviors are more likely in older people and people with dementia. Behaviors usually stop when medication is stopped.

Levodopa (L-DOPA)

check
Data viewer 7 in 100 (7%)

About 14 out of every 100 people (14%) taking dopamine agonists develop impulsive behaviors.


Impulsive behaviors are more likely in older people and people with dementia. Behaviors usually stop when medication is stopped.

Dopamine agonist (enhancer)

check
Data viewer 14 in 100 (14%)
What are the chances of developing impulsive behaviors, like overdoing gambling, eating, sex or shopping?
How important is this question to you?

Not important at all

0 1 2 3 4 5

Extremely important

Frequently Asked Question #5:

What other side effects are possible?

About 28 out of every 100 people (28%) experience nausea, usually when first starting levodopa. This problem can be treated.


About 15 out of every 100 people (15%) experience dizziness.


About 9 out of every 100 people (9%) are sleepy during the day.

Levodopa (L-DOPA)

check
Data viewer 28 in 100 (28%)
Data viewer 15 in 100 (15%)
Data viewer 9 in 100 (9%)

About 30 out of every 100 people (30%) experience nausea, usually when first starting a dopamine agonist. This problem can be treated.


About 17 out of every 100 people (17%) experience dizziness.


About 27 out of every 100 people (27%) are sleepy during the day.

Dopamine agonist (enhancer)

check
Data viewer 30 in 100 (30%)
Data viewer 17 in 100 (17%)
Data viewer 27 in 100 (27%)
What other side effects are possible?
How important is this question to you?

Not important at all

0 1 2 3 4 5

Extremely important

Frequently Asked Question #6:

Will I need more treatment in the future?

Will I need more treatment in the future?
How important is this question to you?

Not important at all

0 1 2 3 4 5

Extremely important

Finished

Based on what you know now, which option are you leaning towards?

Click the option you are currently leaning towards:
How strong is your current preference for this option?

Sure Survey

How do you feel now that you have completed the interactive tool? Please answer these questions:

Question: 1

Do you feel sure about the best choice for you?

Your answer:

check

Yes

check

No

Question: 2

Do you know the benefits and risks of each option?

Your answer:

check

Yes

check

No

Question: 3

Are you clear about which benefits and risks matter most to you?

Your answer:

check

Yes

check

No

Question: 4

Do you have enough support and advice to make a choice?

Your answer:

check

Yes

check

No

Second-to-last step:

Self check

Check your understanding of the information you just read in the Option GridTM decision aid

This time we’ll show you the right answers if you need help!

Question: 1

Levodopa and dopamine agonists (enhancers) work equally well at improving mobility.

Your answer:

check

True

check

False

This is an explanation

Question: 2

More people develop involuntary movements with levodopa compared with dopamine agonists (enhancers).

Your answer:

check

True

check

False

This is an explanation

Question: 3

Impulsive behaviors, such as overeating or gambling, may happen when taking either levodopa or dopamine agonists.

Your answer:

check

True

check

False

This is an explanation

Question: 4

You will probably take the same amount of levodopa for many years.

Your answer:

check

True

check

False

This is an explanation

Question: 5

Taking dopamine agonists means that you won’t have to take levodopa in the future.

Your answer:

check

True

check

False

This is an explanation

Enter any questions you have:

Enter any questions you have which have not been answered by this process.

Your questions will be added to your personalized summary so you can show them to your doctor or loved ones.